Navigation Links
Metabolic engineer synthesizes key breast milk ingredient, makes research possible
Date:9/10/2012

URBANA - A University of Illinois microbial engineer has synthesized a sugar in human milk that is thought to protect babies from pathogens. That's important because 2FL, the shorthand scientists use to describe this human milk oligosaccharide (HMO), has not been added to infant formula because HMOs are incredibly expensive.

"We know these oligosaccharides play a vital role in developing a breast-fed baby's gut microbiota and in strengthening their immunity. 2FL (2-fucosyllactose) is the most abundant HMO in breast milk," said Michael Miller, a U of I professor of food microbiology.

To learn more about the HMO's function, Miller would like to do research with 2FL in newborn piglets, an excellent model for the human infant.

Unfortunately, 1 milligram of 2FL costs $100, meaning a single study would require $1 million for the HMO alone, he said.

Microbiologist, meet metabolic engineer. Yong-Su Jin, a departmental colleague and professor in the U of I's Institute for Genomic Biology, believed he could synthesize this oligosaccharide found in breast milk using a strain of E. coli engineered for that purpose.

A new postdoctoral researcher in Jin's laboratory had done some of the legwork for such a project in Korea, and they used their combined experience and expertise to engineer an HMO that can be produced very cheaply and quickly: 1 gram of 2FL per liter of E. coli broth. That means it's possible to produce 2FL in the lab, making Miller's piglet research feasible, he said.

"E. coli makes a starting material for 2FL as part of its normal metabolism, and that suggested to us that it was possible to use E. coli to produce 2FL," Jin said.

"The trick is to get the E. coli cells to increase their production of the starting material (GDP-fucose), which we did by overexpressing the pre-existing biosynthetic pathway. Then we had to give it the ability to transfer GDP-fucose to lactose. We solved that problem by inserting a gene from another organism," he added.

The next step was developing an E. coli mutant that can assimilate lactose. "Because the engineered mutant cannot use the lactose for its own growth, it instead uses lactose to make great quantities of 2FL, the HMO that many researchers want to study," he said.

Miller will soon be able to begin a study investigating the role of 2FL in infant nutrition and eventually make recommendations about whether it should be added to infant formula. "And we can use this technique to synthesize and study the hundreds of other HMOs in human milk too."

The research has other interesting possibilities unrelated to infant nutrition, he said.

Jin and Miller believe that their work has pharmaceutical applications. "Adding 2FL to the food of soldiers on deployment could keep them out of sick bay. More than half of all soldiers in the field are incapacitated at some point with diarrheal illness caused by Campylobacter jejuni," Jin said.

A second use might be reducing the number of Campylobacter infections that originate in raw or undercooked poultry. "If chickens consumed poultry feed containing 2FL, pathogens would bind to this oligosaccharide instead of the mucosal lining of the bird's intestine and be eliminated well before the chicken arrived at your supermarket," Miller added.


'/>"/>
Contact: Phyllis Picklesimer
p-pickle@illinois.edu
217-244-2827
University of Illinois College of Agricultural, Consumer and Environmental Sciences
Source:Eurekalert

Related medicine news :

1. Obesity and metabolic syndrome associated with impaired brain function in adolescents
2. New research uncovers diverse metabolic roles for PML tumor suppressor gene
3. Ancestral link places Mexican-Americans at greater risk for metabolic disease
4. Metabolic protein wields phosphate group to activate cancer-promoting genes
5. Bees shed light on human sweet perception and metabolic disorders
6. Metabolic Cooking Review For Karine Losier and Dave Ruel's Diet And Cookbook Program Released
7. VCU researchers identify changes in cholesterol metabolic pathways
8. Mutant Kras drives pancreatic cancer maintenance via metabolic pathways
9. Study: Women not getting enough exercise; at risk of developing metabolic syndrome
10. Normal triglyceride levels in people of African descent may hinder diagnosis of metabolic syndrome
11. Engineers improve blood testing technology with smartphone app, hand-held biosensor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... ... 2017 , ... Phytocéane invites clients to take an exotic journey deep into ... ZANZIBAR MILKY CREAM. Inspired by the beauty of Zanzibar, a Tanzanian archipelago off the ... vegetal coral to create this gentle, velvety body cream to envelop the skin in ...
(Date:1/22/2017)... ... ... "Photo Cloud allows FCPX users to add favorited photos to any drop ... Christina Austin - CEO of Pixel Film Studios. , To begin, select a ... include scenes with one, three, four or five focus points. There are five included ...
(Date:1/21/2017)... ... January 21, 2017 , ... Caronlab Australia, an Australian company ... ECRM Trade Show in Hilton Head, SC, where it benefited from outstanding meetings with ... of its beauty and wellness products. At this trade show, the company had the ...
(Date:1/21/2017)... ... 2017 , ... "ProDOF is the perfect set of tools for video editors that want to ... said Christina Austin - CEO of Pixel Film Studios. , Video editors using ProDOF ... of a DSLR racking focus from one area into the next. ProDOF comes with ...
(Date:1/21/2017)... FRANCE (PRWEB) , ... January 21, 2017 , ... ... the Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER GEL. ... Africa, Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to create ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... -- The American Pharmacists Association (APhA) is excited about ... Underserved Areas Enhancement Act (H.R. 592) in ... previously introduced in the 114 th session of ... pharmacists and their patient care services. Sponsors ... (R-KY), G.K. Butterfield (D-NC), Tom Reed ...
(Date:1/23/2017)... Ahead of today,s trading session, Stock-Callers.com draws investors, attention ... the close: Kite Pharma Inc. (NASDAQ: KITE ), BioPharmX ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ). According to a ... January 20 th , 2017, down on the day by about ... now at: ...
(Date:1/23/2017)... WELLESLEY, Massachusetts , January 23, 2017 Longer ... solid growth in the global market for medical device technologies. BCC ... particularly in the Asia-Pacific region, should see strong ... coverage, and rising disposable incomes. Continue Reading ... ...
Breaking Medicine Technology: